Status:
COMPLETED
Effect of EPA and DHA in the Inflammation and Metabolic Disorders in DMD/DMB Patients
Lead Sponsor:
Coordinación de Investigación en Salud, Mexico
Collaborating Sponsors:
Instituto Nacional de Rehabilitacion
Conditions:
Muscular Dystrophy, Duchenne
Eligibility:
MALE
6-18 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the effect of docosahexaenoic fatty acid and eicosapentaenoic fatty acid supplementation for six months on the inflammation state as well as the process of mus...
Detailed Description
DMD and DMB are X-linked diseases caused by mutations in the DMD gene, these mutations have important functional and structural consequences in skeletal muscle. In muscle fiber is observed inflammatio...
Eligibility Criteria
Inclusion
- Written informed consent and assent by the patient and both parents or guardian.
- Patients with clinical diagnosis of Duchenne Muscular Dystrophy (DMD) or Becker Muscular Dystrophy (DMB)
- Patients were not under treatment with corticosteroids
Exclusion
- Patients decided to withdraw from the study
- Consumption of dietary supplements containing polyunsaturated fatty acids omega 3.
- With hypersensitivity to fish oil.
- Patients with respiratory and gastrointestinal problems. Medical responsible assessment the presence of respiratory and gastrointestinal problems.
- Patients with difficulty swallowing food, including those who have the difficulty ingesting oil capsules.
- Gastrostomy fed patients.
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2017
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01826422
Start Date
March 1 2013
End Date
January 1 2017
Last Update
March 9 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unit of Medical Researcha in Nutrition, Pediatric Hospital, IMSS.
Mexico City, Mexico, 06720